loading
Precedente Chiudi:
$4.33
Aprire:
$4.33
Volume 24 ore:
88,923
Relative Volume:
1.06
Capitalizzazione di mercato:
$43.31M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00116
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
+2.50%
1M Prestazione:
-14.23%
6M Prestazione:
-59.61%
1 anno Prestazione:
-62.69%
Intervallo 1D:
Value
$4.06
$4.49
Intervallo di 1 settimana:
Value
$3.93
$4.71
Portata 52W:
Value
$3.39
$16.00

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Name
Nome
Avalo Therapeutics Inc
Name
Telefono
410-522-8707
Name
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
AVTX's Discussions on Twitter

Confronta AVTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AVTX
Avalo Therapeutics Inc
4.10 43.31M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Ripresa H.C. Wainwright Buy
2025-03-25 Iniziato Jefferies Buy
2025-03-25 Iniziato Stifel Buy
2025-02-28 Iniziato Piper Sandler Overweight
2025-02-21 Iniziato Wedbush Outperform
2024-12-19 Iniziato BTIG Research Buy
2024-10-24 Iniziato H.C. Wainwright Neutral
2024-04-16 Aggiornamento Oppenheimer Perform → Outperform
2021-09-24 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie

pulisher
Jun 05, 2025

Avalo Therapeutics Signs New Sales Agreement - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. Wainwright upgrades Avalo Therapeutics stock to buy By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

AVTX: Avalo Therapeutics Receives Buy Rating with $15 Target Pri - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Avalo Therapeutics (AVTX) Receives Buy Rating from H.C. Wainwright | AVTX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cardax (OTCMKTS:CDXI) and Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Analysis - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World

May 31, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferenc - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 27, 2025
pulisher
May 17, 2025

Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Bought by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 13, 2025

Strong Cash Position Secures AVTX Through 2027 | AVTX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Avalo Therapeutics Reports Improved Financial Performance - TipRanks

May 13, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics reports Q1 EPS ($1.25) vs. ($141.14) last year - TipRanks

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

AVTX Advances Phase 2 LOTUS Trial, Targets 2026 Data | AVTX Stoc - GuruFocus

May 12, 2025
pulisher
May 12, 2025

AVALO THERAPEUTICS Earnings Results: $AVTX Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Bu - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics Announces Leadership Change and Updates on AVTX-009 Phase 2 Trial for Hidradenitis Suppurativa - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Avalo Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire Inc.

May 12, 2025
pulisher
May 10, 2025

Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 08, 2025

Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks

May 08, 2025
pulisher
May 07, 2025

15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World

May 07, 2025
pulisher
May 06, 2025

When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com

May 06, 2025
pulisher
May 06, 2025

Avalo Therapeutics Enters $75 Million Sales Agreement With TD Cowen For Common Stock Offering - marketscreener.com

May 06, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025
pulisher
Apr 23, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World

Apr 22, 2025
pulisher
Apr 22, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World

Apr 22, 2025
pulisher
Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Seven new option listings and one option delisting on April 16th - TipRanks

Apr 16, 2025
pulisher
Apr 15, 2025

Avalo Therapeutics Reports 2024 Financial Results - TipRanks

Apr 15, 2025
pulisher
Apr 09, 2025

Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com

Apr 09, 2025
pulisher
Apr 04, 2025

(AVTX) On The My Stocks Page - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Mar 29, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Stifel Nicolaus - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Avalo Therapeutics (AVTX) to Release Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Names Michael Heffernan as Board Chairman - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board - MarketScreener

Mar 26, 2025

Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):